Canopus BioPharma Incorporated

OTCPK:CBIA Stock Report

Market Cap: US$389.9k

Canopus BioPharma Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Patrick Prendergast

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure17.3yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates


CEO

Patrick Prendergast

17.3yrs

Tenure

Mr. Patrick T. Prendergast has been Chairman and Chief Executive Officer of Canopus Biopharma, Inc. since July 2007.